{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:57:06Z","timestamp":1791979026811,"version":"4.4.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020584","name":"Region Hovedstadens Psykiatri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007371","name":"Svend Andersen Fonden","doi-asserted-by":"publisher","award":["03\\u201310\\u20132022"],"award-info":[{"award-number":["03\\u201310\\u20132022"]}],"id":[{"id":"10.13039\/501100007371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neubiorev.2026.106574","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:51:29Z","timestamp":1769323889000},"page":"106574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antithrombotic agents in the treatment of severe mental illness: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-358X","authenticated-orcid":false,"given":"Caroline Fussing","family":"Bruun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Ungermann","family":"Fredskild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Faurholt-Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Vinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Vedel","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Munkholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2026.106574_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-10-2","article-title":"Guidelines for rating Global Assessment of Functioning (GAF)","volume":"10","author":"Aas","year":"2011","journal-title":"Ann. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2710.2000.00273.x","article-title":"Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions","volume":"25","author":"Akhondzadeh","year":"2000","journal-title":"J. Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib3","doi-asserted-by":"crossref","DOI":"10.5812\/ijpbs.5848","article-title":"Aspirin inclusion in antipsychotic treatment on severity of symptoms in schizophrenia: a randimized clinical trial","volume":"11","author":"Attari","year":"2017","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib4","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12200","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and n-acetylcysteine as adjunctive treatments for bipolar depression","volume":"80","author":"Bauer","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib5","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12200","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression","volume":"80","author":"Bauer","year":"2019","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12916-019-1475-6","article-title":"Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin","volume":"18","author":"Berk","year":"2020","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106574_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jad.2011.10.012","article-title":"Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability","volume":"136","author":"Bonn\u00edn","year":"2012","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106574_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2011.11.016","article-title":"Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study","volume":"46","author":"Canan","year":"2012","journal-title":"J. Psychiatr. Res"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106574_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbu016","article-title":"Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder","volume":"40","author":"Cardno","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2026.106574_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbi.2024.03.029","article-title":"A composite immune and vascular stress marker in patients newly diagnosed with bipolar disorder and their unaffected first-degree relatives","volume":"118","author":"Coello","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106574_bib12","unstructured":"Covidence systematic review software. Veritas Health Innovation."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106574_bib13","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1038\/s41380-025-03032-x","article-title":"Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions","volume":"30","author":"Dardani","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106574_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0447.1986.tb02723.x","article-title":"The montgomery-asberg depression scale: reliability and validity","volume":"73","author":"Davidson","year":"1986","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2026.106574_bib15","article-title":"Immune dysregulation and neuroinflammation in bipolar disorder: pathophysiological insights and therapeutic perspectives","volume":"52","author":"De Cillis","year":"2026","journal-title":"Brain Behav. Immun. Health"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/j.2051-5545.2011.tb00036.x","article-title":"Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","article-title":"The intriguing relationship between coronary heart disease and mental disorders","volume":"20","author":"De Hert","year":"2018","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106574_bib18","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 10: Analysing Data and Undertaking Meta-Analyses","author":"Deeks","year":"2023"},{"key":"10.1016\/j.neubiorev.2026.106574_bib19","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 8: Assessing risk of bias in a randomized trial","author":"Deeks","year":"2023"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106574_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"WHOQOL-BREF quality of life assessment. The WHOQOL Group","volume":"28","author":"Development of the World Health Organization","year":"1998","journal-title":"Psychol. Med"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010067","article-title":"Acetylsalicylic acid and mood disorders: a systematic review","volume":"16","author":"Dominiak","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/wps.21068","article-title":"Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction","volume":"22","author":"Dragioti","year":"2023","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib23","first-page":"e89S","article-title":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest Physicians Evid. Based Clin. Pract. Guidel. Chest"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/wps.20631","article-title":"Transdiagnostic psychiatry: a systematic review","volume":"18","author":"Fusar-Poli","year":"2019","journal-title":"World Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106574_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacc.2022.06.017","article-title":"Severe mental illness and cardiovascular disease: JACC state-of-the-art review","volume":"80","author":"Goldfarb","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neubiorev.2026.106574_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-244X-13-127","article-title":"The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients","volume":"13","author":"G\u00f3mez-Benito","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106574_bib27","volume":"10","author":"Guideline","year":"2014"},{"key":"10.1016\/j.neubiorev.2026.106574_bib28","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.neubiorev.2026.106574_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jad.2016.08.018","article-title":"Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: associations with functional abilities","volume":"205","author":"Jensen","year":"2016","journal-title":"J. Affect Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(88)90038-8","article-title":"Reliability and validity of the positive and negative syndrome scale for schizophrenics","volume":"23","author":"Kay","year":"1988","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106574_bib31","first-page":"B5160","article-title":"Course and cognitive outcome in major affective disorder","volume":"62","author":"Kessing","year":"2015","journal-title":"Dan. Med J."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/acps.12667","article-title":"Evidence for clinical progression of unipolar and bipolar disorders","volume":"135","author":"Kessing","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106574_bib33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bdi.12772","article-title":"New drug candidates for bipolar disorder-A nation-wide population-based study","volume":"21","author":"Kessing","year":"2019","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-021-06041-0","article-title":"Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial","volume":"239","author":"Khadivi","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2026.106574_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/bjp.131.1.49","article-title":"Validity of the Hamilton Rating Scale for depression","volume":"131","author":"Knesevich","year":"1977","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106574_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106574_bib37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106574_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003960","article-title":"Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis","volume":"19","author":"Lambert","year":"2022","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106574_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106574_bib40","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41380-024-02552-2","article-title":"Exploring the genetic etiology across the continuum of the general psychopathology factor: a Swedish population-based family and twin study","volume":"29","author":"Liu","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106574_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119786","article-title":"Association between brain similarity to severe mental illnesses and comorbid cerebral, physical, and cognitive impairments","volume":"265","author":"Ma","year":"2023","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106574_bib42","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"10161","key":"10.1016\/j.neubiorev.2026.106574_bib43","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.106574_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.573479","article-title":"Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness","volume":"11","author":"Mazereel","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106574_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200607000-00005","article-title":"Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study","volume":"21","author":"Mendlewicz","year":"2006","journal-title":"Int Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106574_bib46","first-page":"391","article-title":"Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder","volume":"18","author":"Miller","year":"2020","journal-title":"Focus (Am. Psychiatr. Publ. )"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106574_bib47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/bdi.13193","article-title":"Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force","volume":"24","author":"Miskowiak","year":"2022","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106574_bib48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH14-11-0947","article-title":"Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD","volume":"114","author":"M\u00fcller","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1017\/S1092852918001207","article-title":"Cognitive impairment in major depressive disorder","volume":"24","author":"Pan","year":"2019","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106574_bib50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000319530","article-title":"Clinical implications of the cytokine hypothesis of depression: The association between use of statins and aspirin and the risk of major depression","volume":"79","author":"Pasco","year":"2010","journal-title":"Psychother. Psychosom."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.32598\/irj.20.1.962.3","article-title":"Comparing the effects of adjunct aspirin and simvastatin on psychopathology among inpatients with schizophrenia","volume":"20","author":"Pourghasem","year":"2022","journal-title":"Iran. Rehabil. J."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106574_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2583","article-title":"Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study","volume":"32","author":"Rezaei","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2026.106574_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin. Pr. Epidemiol. Ment. Health"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106574_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1192\/bjp.bp.109.076489","article-title":"Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders","volume":"197","author":"Saarni","year":"2010","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106574_bib55","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bdi.12108","article-title":"Aspirin for treatment of lithium-associated sexual dysfunction in men: Randomized double-blind placebo-controlled study","volume":"15","author":"Saroukhani","year":"2013","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106574_bib57","first-page":"Cd012116","article-title":"Acetylsalicylic acid (aspirin) for schizophrenia","volume":"8","author":"Schmidt","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2026.106574_bib58","unstructured":"Sch\u00fcnemann H.B.J., Guyatt G., Oxman A. Grade handbook for grading quality of evidence and strength of recommendations. 2013."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106574_bib59","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.19082\/57","article-title":"The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial","volume":"9","author":"Sepehrmanesh","year":"2017","journal-title":"Electron Physician"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106574_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","article-title":"Platelet\/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1358863X07077462","article-title":"Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease","volume":"12","author":"Steinhubl","year":"2007","journal-title":"Vasc. Med"},{"key":"10.1016\/j.neubiorev.2026.106574_bib62","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106574_bib63","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/schbul\/sbaa198","article-title":"Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials","volume":"47","author":"Weiser","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106574_bib64","first-page":"1","article-title":"Statin and aspirin use and the risk of mood disorders among men","volume":"19","author":"Williams","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106574_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2026.106574_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107322","article-title":"\u201cInflamed\u201d depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression","volume":"207","author":"Yin","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2026.106574_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106574_bib68","first-page":"401","article-title":"Depression and physical health, the therapeutic alliance and antidepressants","volume":"30","author":"Zdanowicz","year":"2018","journal-title":"Psychiatr. Danub"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106574_bib69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11239-007-0189-3","article-title":"Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study","volume":"27","author":"van Zyl","year":"2009","journal-title":"J. Thromb. Thrombolysis"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:31:03Z","timestamp":1773988263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"alternative-id":["S0149763426000291"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106574","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic agents in the treatment of severe mental illness: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106574"}}